Related references
Note: Only part of the references are listed.NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
Stephen R. Mattarollo et al.
BLOOD (2012)
Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia
Farhad Jadidi-Niaragh et al.
MEDICAL ONCOLOGY (2012)
Targeting natural killer cells and natural killer T cells in cancer
Eric Vivier et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL
Petros Christopoulos et al.
BLOOD (2011)
Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer
Shinichiro Motohashi et al.
CLINICAL IMMUNOLOGY (2011)
Harnessing natural killer T (NKT) cells in human myeloma: Progress and challenges
Madhav V. Dhodapkar et al.
CLINICAL IMMUNOLOGY (2011)
CD3(+)/CD16(+)CD56(+) cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma
Iwona Hus et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2011)
Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features
Sarah E. Gibson et al.
HUMAN PATHOLOGY (2011)
A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties
Adam P. Uldrich et al.
NATURE IMMUNOLOGY (2011)
CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis
Laura M. Hix et al.
PLOS ONE (2011)
Tumour-loaded α-type 1-polarized Dendritic Cells from Patients with Chronic Lymphocytic Leukaemia Produce a Superior NK-, NKT- and CD8+ T Cell-attracting Chemokine Profile
Karin Gustafsson et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Ex vivo Expansion of CD56+ NK and NKT-like Lymphocytes from Peripheral Blood Mononuclear Cells of Patients with Ovarian Neoplasia
P. C. M. Alves et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV
Shiho Miura et al.
JOURNAL OF VIROLOGY (2010)
Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: Intracellular cytokine expression and relationship with clinical outcome
Agnieszka Bojarska-Junak et al.
ONCOLOGY REPORTS (2010)
Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells
Maria Blomqvist et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms
Davide Bagnara et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
TCR-inducible PLZF transcription factor required for innate phenotype of a subset of γδ T cells with restricted TCR diversity
Taras Kreslavsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
David H. Chang et al.
BLOOD (2008)
Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma
Gourapura J. Renukaradhya et al.
BLOOD (2008)
Clinical applications of natural killer T cell-based immunotherapy for cancer
Shinichiro Motohashi et al.
CANCER SCIENCE (2008)
Generation of Antitumor Invariant Natural Killer T Cell Lines in Multiple Myeloma and Promotion of Their Functions via Lenalidomide: A Strategy for Immunotherapy
Weihua Song et al.
CLINICAL CANCER RESEARCH (2008)
CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system
Jennifer L. Matsuda et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism
M. Mahmood Hussain et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
The transcription factor PLZF directs the effector program of the NKT cell lineage
Adam K. Savage et al.
IMMUNITY (2008)
Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type IINKT cells
Keshab Chandra Roy et al.
JOURNAL OF IMMUNOLOGY (2008)
The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions
Damian Kovalovsky et al.
NATURE IMMUNOLOGY (2008)
CD1 antigen presentation: how it works
Duarte C. Barral et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection
Lucy Golden-Mason et al.
JOURNAL OF VIROLOGY (2007)
Control points in NKT-cell development
Dale I. Godfrey et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells
Nicolas Schrantz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
MTP regulated by an alternate promoter is essential for NKT cell development
Stephanie K. Dougan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells
Kyoko Haraguchi et al.
LEUKEMIA & LYMPHOMA (2006)
Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications
David H. Chang et al.
BLOOD (2006)
CD4+CD25+ Tregs and NKT cells:: regulators regulating regulators
Antonio La Cava et al.
TRENDS IN IMMUNOLOGY (2006)
Adoptive immunotherapy for cancer: building on success
L Gattinoni et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Differential antitumor immunity mediated by NKT cell subsets in vivo
NY Crowe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Peripheral blood IFN-γ-secreting Vα24+Vβ11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load
JW Molling et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes
DG Wei et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny
JS Bezbradica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13
JM Park et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Regulation of NKT cell development by SAP, the protein defective in XLP
KE Nichols et al.
NATURE MEDICINE (2005)
The peripheral blood Vα24+NKT cell numbers decrease in patients with haematopoietic malignancy
K Yoneda et al.
LEUKEMIA RESEARCH (2005)
Toward an understanding of NKT cell biology: Progress and paradoxes
M Kronenberg
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Cd1d is expressed on B-chronic lymphocytic leukemia cells and mediates α-galactosylceramide presentation to natural killer T lymphocytes
F Fais et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
NF-κB controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes
AK Stanic et al.
JOURNAL OF IMMUNOLOGY (2004)
CD1d-restricted T cell activation by nonlipidic small molecules
I Van Rhijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CD1: Antigen presentation and T cell function
M Brigl et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion
KM Dhodapkar et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy
H Guven et al.
LEUKEMIA (2003)
CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells
SY Thomas et al.
JOURNAL OF IMMUNOLOGY (2003)
NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells
T Kenna et al.
JOURNAL OF IMMUNOLOGY (2003)
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1
E Treiner et al.
NATURE (2003)
Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide
J Schmieg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs
S Fujii et al.
NATURE IMMUNOLOGY (2002)
Trafficking machinery of NKT cells:: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacity
CH Kim et al.
BLOOD (2002)
A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas
NY Crowe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells
V Sriram et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Vα24-JαQ-independent, CD1d-restricted recognition of α-galactosylceramide by human CD4+ and CD8αβ+ T lymphocytes
SD Gadola et al.
JOURNAL OF IMMUNOLOGY (2002)
γδ T cells:: Functional plasticity and heterogeneity
SR Carding et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells
LS Metelitsa et al.
JOURNAL OF IMMUNOLOGY (2001)
TRAIL expression by activated human CD4+Vα24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukema cells
M Nieda et al.
BLOOD (2001)
Expression of xenoantigen transformed human cancer cells to be susceptible to antibody-mediated cell killing
N Yoshimura et al.
CANCER LETTERS (2001)
Molecular biology of NK T cell specificity and development
D Elewaut et al.
SEMINARS IN IMMUNOLOGY (2000)
NKT cells: facts, functions and fallacies
DI Godfrey et al.
IMMUNOLOGY TODAY (2000)
NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells
MC Coles et al.
JOURNAL OF IMMUNOLOGY (2000)
Differential tumor surveillance by natural killer (NK) and NKT cells
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
